Journal Mobile Options
Table of Contents
Vol. 8, No. 3, 2005
Issue release date: August 2005
Community Genet 2005;8:186–196
(DOI:10.1159/000086764)

United Arab Emirates: Communities and Community Genetics

Al-Gazali L.I. · Alwash R. · Abdulrazzaq Y.M.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

The UAE society is cosmopolitan, but the indigenous inhabitants are traditional with puritanical values despite their exposure to other vastly different cultures and habits. Marriages between consanguineous couples are still the norm rather than the exception. As a result, there is a high frequency of genetic disorders, particularly autosomal recessive types. Despite the high frequency of genetic disorders like haemoglobinopathies and others characteristically found in this population, genetic services are inadequate. Screening for certain disorders like thalassaemia are not applied on a wide scale. Abortion is illegal, and therefore, prenatal diagnosis or preconception tests are not done. With the absence of a good national database, deficiency of genetic services and absence of preventative alternatives for carrier couples, genetic counsellors find it difficult to advice pragmatic solutions to issues relating to genetic diseases. This paper reviews common genetic problems in the UAE with special emphasis on available genetic services and support to families with children with inherited disorders. Existing barriers to the improvement of clinical services by prenatal counselling are also discussed.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Alwash R, Abbas A: Public health practice in UAE. Public Health Med 1999;1:113–117.
  2. Shihab M: Social and economic changes in the United Arab Emirates; in Gareeb E, Al Abed I (eds): Perspectives on the United Arab Emirates. London, Trident Press, 1997, pp 290–300.
  3. Heard-Bay F: The tribal society of the UAE and its traditional economy; in Gareeb E, Al Abed I (eds): Perspectives on the United Arab Emirates. London, Trident Press, 1999, pp 254–272.
  4. Heard-Bay F: The people of the UAE. Em Nat Hist Group (Abu Dhabi) 1976;5:11–15.
  5. Abdulla MM: The United Arab Emirates: A Modern History. New York, Harper and Row, 1978, pp 221–243.
  6. Ramahi SA: Economic and political evolution in the Arabian Gulf States. New York, Carlton Press, 1973, pp 42, 45, 57, 81, 203.
  7. Quaife R, Al-Gazali LI, Abbes S, Fitzgerald P, Old J: Spectrum of beta thalassaemia mutations in the UAE national population. J Med Genet 1994;34:59–61.
  8. Annual Report, Ministry of Health, United Arab Emirates, 1993.
  9. Abdulrazzaq YM, Bener A, Al-Gazali LI, Al-Khayat AI, Micallef R, Gaber T: A study of possible deleterious effect of consanguinity. Clin Genet 1997;51:167–173.
  10. Annual Report, Ministry of Health, United Arab Emirates, 2000.
  11. Al-Gazali LI, Bener A, Abdulrazzaq YM, Micallef R, Al-Kayat AI, Gaber T: Consanguineous marriages in the United Arab Emirates. J Biosoc Sci 1997;29:491–497.
  12. Al-Gazali LI: Attitudes towards genetic counseling in the United Arab Emirates. Community Genet 2005;8:48–51.
  13. Baysal E: Molecular heterogeneity of β-thalassemia in the United Arab Emirates. Community Genet 2005;8:35–39.
  14. Baysal E: Hemoglobinopathies in the United Arab Emirates. Hemoglobin 2001;25:247–253.
  15. El-Kalla S, Baysal E: Alpha-thalassemia in the United Arab Emirates. Acta Haematol 1998;100:49–53.
  16. White JM, Christie BS, Nam D, Daar S, Higg DR: Frequency and clinical significance of erythrocyte genetic abnormalities in Omanis. J Med Genet 1993;30:396–400.
  17. Awaad M, Bayoumi R: Sickle cell disease in adult Bedouins of Al Ain district, UAE. Em Med J 1993;11:21–24.
  18. White JM, Byrne M, Richards R, Buchanan T, Katsoulis E, Weerasingh K: Red cell genetic abnormalities in Peninsular Arabs: Sickle haemoglobin, G6PD deficiency, and alpha and beta thalassaemia. J Med Genet 1986;23:245–251.
  19. Kamel K: Heterogeneity of sickle cell anaemia in Arabs: Review of cases with various amounts of fetal haemoglobin. J Med Genet 1979;16:428–430.
  20. Abbes S, Rad A, Fitzgerald P, Dormer P, Blouquit Y, Kister J, Galacteros F, Wajeman H: HB Al Ain Abu Dhabi [α 18(A16)Gly → Asp]: A new hemoglobin variant discovered in an Emiratee family. Hemoglobin 1992;16:355–362.
  21. Bayoumi RA, Nur-E-Kamal MSA, Tadayyon M, Mohamed KKA, Mahboob BH, Qureshi MM, Lakhani MG, Ausiad MO, Kaeda J, Vullamy TJ, Luzzatto L: Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Al Ain district, United Arab Emirates. Hum Hered 1996;46:136–141.
  22. Abdulrazzaq YM, Micallef R, Qureshi MM, Dawodu A, Ahmed I, Khidr A, Bastaki SMA, Al-Kayat AI, Bayoumi RA: Diversity in expression of glucose-6-phosphate dehydrogenase deficiency in females. Clin Genet 1999;55:13–19.
  23. Mohammed AM, Al-Hilli F, Nadkarni KV, Bhagwat GP, Bapat JP: Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain. Ann Saudi Med 1992;12:536–539.

    External Resources

  24. Benson PF, Fahmy NA, Vaswani K, Semrin A: Cystic fibrosis in the United Arab Emirates. A case report. Em Med J 1987;5:156–157.
  25. Abdul Aziz S, Salem F, Gohary A: Cystic fibrosis in the United Arab Emirates. Em Med J 1991;9:202–204.
  26. Frossard P, Hertecant J, Bossard Y, Dawson KP: Genotype-phenotype correlations in cystic fibrosis: Clinical severity of mutation S549R (T → G). Eur Respir J 1999;13:100–102.
  27. Dawson K, Frossard P: Cystic fibrosis in the UAE: Clinical presentation. Em Med J 1994;12:245–247.
  28. Frossard P, Lestringant G, Girodon E, Goossens M, Dawson K: Determination of the prevalence of cystic fibrosis in the United Arab Emirates by genetic carrier screening. Clin Genet 1999;55:496–497.
  29. Al-Gazali LI: A genetic aetiological survey of severe childhood deafness in the United Arab Emirates. J Trop Pediatr 1998;44:157–160.
  30. Campbell DA, McHale DP, Brown KA, Moynihan LM, Houseman M, Karbani G, Parry G, Janjua AH, Newton V, Al-Gazali LI, Markham AF, Lench NJ, Mueller RF: A new locus for non-syndromal autosomal recessive sensorineural hearing loss (DFNB16) maps to human chromosome 15q21-q22. J Med Genet 1997;34:1015–1017.
  31. Pulleyn LJ, Jackson AP, Roberts E, Carridice A, Muxworthy C, Houseman M, Al-Gazali LI, Lench NJ, Markham AF, Mueller RF: A new locus for autosomal recessive non-syndromal sensorineural hearing impairment (DFNB27) on chromosome 2q23-q31. Eur J Hum Genet 2000;8:991–993.
  32. Houseman MJ, Jackson AP, Al-Gazali LI, Badin RA, Roberts E, Mueller RF: A novel mutation in a family with non-syndromic sensorineural hearing loss that disrupt the newly characterized OTOF long isoform. J Med Genet 2001;38:E25.

    External Resources

  33. Al-Gazali LI, Sztriha L, Dawodu A, Bakir M, Varghese M, Varady E, Scorer J, Abdulrazzaq YM, Bener A, Padmanabhan R: Pattern of central nervous system anomalies in a population with a high rate of consanguineous marriages. Clin Genet 1999;55:95–102.
  34. Saar K, Al-Gazali LI, Sztriha L, Rueschendorf F, Nur-E-Kamal MSA, Reis A, Bayoumi R: Homozygosity mapping in families with Joubert syndrome identifies a locus on chromosome 9q34.3 and evidence for genetic heterogeneity. Am J Hum Genet 1999;65:1666– 1671.
  35. Keeler LC, Marsh SE, Leeflang EP, Woods CG, Guru Raj A, Al-Gazali LI, Sztriha L, Gleeson JG: Linkage analysis in families with Joubert syndrome plus oculo-renal involvement identifies the CORS2 locus on chromosome 11p12-q13.3. Am J Hum Genet 2003;73:656–662.
  36. Teebi A, Farag T: Genetic Disorders among Arab Populations. Oxford Monographs on Medical Genetics. New York, Oxford University Press, 1997.
  37. Al-Gazali LI: Genetic disorders in the UAE; in Teebi A, Farag T (eds): Genetic Disorders among Arab Populations. New York, Oxford University Press, 1997, pp 341–372.
  38. Al-Gazali LI, Bakir M, Hamid Z, Varady E, Varghese M, Haas D, Bener A, Padmanabhan R, Abdulrazzaq YM, Dawadu A: Birth prevalence and pattern of osteochondrodysplasias in an inbred high risk population. Birth Defects Res A Clin Mol Teratol 2003;125:125–132.
  39. Dagoneau N, Scheffer D, Huber C, Al-Gazali LI, Di Rocco M, Godard A, Marrinovic J, Raas-Rothschild A, Sigaudy S, Unger S, Nicole S, Fontaine B, Taupin J, Moreau J, Superti-Furga A, Le Merrer M, Bonaventure J, Munnich A, Legeai-Mallet L, Cormier-Daire V: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel 2 syndrome. Am J Hum Genet 2004;74:298–305.
  40. Bayoumi R, Saar K, Nurnberg G, Reis A, Nur-E-Kamal M, Al-Gazali LI: Localization of a gene for an autosomal recessive syndrome of macrocephaly, multiple epiphyseal dysplasia (MED) and distinctive facies to chromosome 15q26. J Med Genet 2001;38:369–373.
  41. Al-Gazali LI, Bakalinova D, Sztriha L: Spondylo-meta-epiphyseal dysplasia, short limb, abnormal calcification type. Clin Dysmorphol 1996;5:197–206.
  42. Al-Gazali LI, Davedas K, Hall C: A new lethal neonatal short limb dwarfism. Clin Dysmorphol 1996;5:159–164.
  43. Giunta C, Randolph A, Al-Gazali LI, Brunner HG, Kraenzlin ME, Steinmann B: The Nevo syndrome is allelic to the kyphoscoliotic type of Ehlers-Danlos syndrome VIA (EDS VIA)-expansion of the phenotype. Am J Med Genet, in press.
  44. Nakano A, Lestringant G, Paperna T, Bergman R, Greshoni R, Frossard P, Kanaan M, Meneguzzi G, Pulkkinen L, Sprecher E: Junctional epidermolysis bullosa in the Middle East: Clinical and genetic studies in a series of consanguineous families. J Am Acad Dermatol 2002;46:510–516.
  45. Allegra M, Gagnoux-Palacios L, Gache Y, Roques S, Lestringant G, Ortonne J, Meneguzzi G: Rapid decay of alpha 6 integrin caused by a mis-sense mutation in the propeller domain results in severe junctional epidermolysis bullosa with pyloric atresia. J Invest Dermatol 2003;121:1336–1346.
  46. Eckl KM, Stevens HP, Lestringant G, Westenberger-Treumann M, Traupe H, Hinz B, Frossard PM, Stadler R, Leigh IM, Nurnberg P, Reis A, Hennies HC: Mal de Meleda caused by mutations in the gene for SLURP-1 in patients from Germany, Turkey, Palestine, and the United Arab Emirates. Hum Genet 2003;112:50–56.
  47. Al-Gazali LI, Sztriha L, Sakaff F, Hass D: Gerodermia osteodysplatica and wrinkly skin syndrome: Are they the same. Am J Med Genet 2001;101:213–220.
  48. Ozand P, Gascon G: Neurometabolic diseases at a national referral center: Five years experience at the King Faisal Specialist Hospital and Research Center. J Child Neurol 1992;7 (suppl):S4–S11.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50